PolyPid Ltd. (PYPD)
Data as of , from SEC Form 4 filings.
See up to 3 months of PYPD. The 7-day demo opens the 1M and 3M ranges and puts PYPD on your watchlist.
Start 7-day demoLatest PYPD insider trades
Ori Warshavsky - OfficerGrant or award$205K- Jonathan Missulawin - OfficerGrant or award$219K
- Dalit Fellous Hazan - Officer
About PolyPid Ltd. (PYPD)
PolyPid Ltd. is an SEC registrant, filing under CIK 0001611842, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
PYPD Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 373,792 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PYPD insider transactions (Form 4)
1010 Form 4 filings on record, the earliest from Jul 17, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ori Warshavsky - Officer | Grant or award | Stock option (right to buy) | 46,000 | $4.46 | $205K | |
| Jonathan Missulawin - Officer | Grant or award | Stock option (right to buy) | 49,000 | $4.46 | $219K | |
| Dalit Fellous Hazan - Officer | Grant or award | Stock option (right to buy) | 75,000 | $4.46 | $335K | |
| Yechezkel Barenholz - Director | Grant or award | Stock option (right to buy) | 9,132 | $4.46 | $41K | |
| Robert Benjamin Stein - Director | Grant or award | Stock option (right to buy) | 9,132 | $4.46 | $41K | |
| Nir Dror-Darwish - Director | Grant or award | Stock option (right to buy) | 9,132 | $4.46 | $41K | |
| Joseph Benamram - Director | Grant or award | Stock option (right to buy) | 9,132 | $4.46 | $41K | |
| Itzhak Krinsky - Director | Grant or award | Stock option (right to buy) | 9,132 | $4.46 | $41K | |
| Brooke Story - Director | Grant or award | Stock option (right to buy) | 9,132 | $4.46 | $41K | |
| Dikla Czaczkes Akselbrad - Officer | Grant or award | Stock option (right to buy) | 149,000 | $4.46 | $665K |
PYPD insider trading FAQ
What is the latest insider trade for PYPD?
PolyPid Ltd. (PYPD) had 10 insider filings in the last 90 days, with the most recent on 2026-07-17. The full record for PYPD runs to 10 Form 4 filings, the earliest from 2026-07-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PYPD stock?
No insider purchases of PYPD were filed in the last 90 days.
How many insiders are selling PYPD stock?
No insider sales of PYPD were filed in the last 90 days.
Where can I see PYPD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PYPD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ori Warshavsky view on EDGAR
- - Jonathan Missulawin view on EDGAR
- - Dalit Fellous Hazan view on EDGAR
- - Yechezkel Barenholz view on EDGAR
- - Robert Benjamin Stein view on EDGAR
- - Nir Dror-Darwish view on EDGAR
- - Joseph Benamram view on EDGAR
- - Itzhak Krinsky view on EDGAR
- - Brooke Story view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PYPD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PYPD with a 7-day demo
- PYPD on your watchlist
- Every PYPD Form 4 filing on record
- Up to 3 months of PYPD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
